Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBsAg seroclearance after discontinuation of tenofovir or entecavir
TCTR20190609001Phase 3Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir, entecavir in Chronic Hepatitis B (CHB), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Apr 2019; status: recruiting.
02
Drugs
tenofovirentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on TCTR20190609001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190609001.